MVR-T3011 (T3011)
Advanced Solid Tumors (melanoma, head and neck squamous cell carcinoma)
Phase 1/2Active
Key Facts
Indication
Advanced Solid Tumors (melanoma, head and neck squamous cell carcinoma)
Phase
Phase 1/2
Status
Active
Company
About ImmVira
Clinical-stage biotech developing engineered oncolytic herpes simplex virus therapies for solid tumor cancers.
View full company profile